JP2022522890A5 - - Google Patents
Info
- Publication number
- JP2022522890A5 JP2022522890A5 JP2021552591A JP2021552591A JP2022522890A5 JP 2022522890 A5 JP2022522890 A5 JP 2022522890A5 JP 2021552591 A JP2021552591 A JP 2021552591A JP 2021552591 A JP2021552591 A JP 2021552591A JP 2022522890 A5 JP2022522890 A5 JP 2022522890A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- tautomers
- stereoisomers
- acceptable salts
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/076926 | 2019-03-05 | ||
| PCT/CN2019/076926 WO2020177067A1 (en) | 2019-03-05 | 2019-03-05 | Aromatic derivatives, preparation methods, and medical uses thereof |
| PCT/CN2020/075849 WO2020177534A1 (en) | 2019-03-05 | 2020-02-19 | Aromatic derivatives, preparation methods, and medical uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022522890A JP2022522890A (ja) | 2022-04-20 |
| JP2022522890A5 true JP2022522890A5 (https=) | 2023-02-28 |
| JP7470708B2 JP7470708B2 (ja) | 2024-04-18 |
Family
ID=72337401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552591A Active JP7470708B2 (ja) | 2019-03-05 | 2020-02-19 | 芳香族誘導体、その調製方法および医薬用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11976058B2 (https=) |
| EP (1) | EP3935048A4 (https=) |
| JP (1) | JP7470708B2 (https=) |
| KR (1) | KR20210135558A (https=) |
| CN (1) | CN111902400B (https=) |
| CA (1) | CA3132405A1 (https=) |
| PH (1) | PH12021552133A1 (https=) |
| SG (1) | SG11202109522VA (https=) |
| TW (1) | TWI860334B (https=) |
| WO (2) | WO2020177067A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12595371B2 (en) | 2018-03-02 | 2026-04-07 | Johnson & Johnson Vision Care, Inc. | Contact lens with improved vision break-up time |
| US12595370B2 (en) | 2018-03-02 | 2026-04-07 | Johnson & Johnson Vision Care, Inc. | Polymerizable absorbers of UV and high energy visible light |
| US20220194944A1 (en) * | 2020-12-18 | 2022-06-23 | Johnson & Johnson Vision Care, Inc. | Photostable mimics of macular pigment |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6043347B2 (ja) | 2011-06-16 | 2016-12-14 | アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 線維芽細胞増殖因子受容体４の発現のアンチセンス調節 |
| SG11201500125QA (en) | 2012-07-11 | 2015-02-27 | Blueprint Medicines Corp | Inhibitors of the fibroblast growth factor receptor |
| CN105307657B (zh) | 2013-03-15 | 2020-07-10 | 西建卡尔有限责任公司 | 杂芳基化合物和其用途 |
| US10124003B2 (en) | 2013-07-18 | 2018-11-13 | Taiho Pharmaceutical Co., Ltd. | Therapeutic agent for FGFR inhibitor-resistant cancer |
| PH12016500676B1 (en) | 2013-10-18 | 2022-07-20 | Eisai R&D Man Co Ltd | Pyrimidine fgfr4 inhibitors |
| TN2016000115A1 (en) | 2013-10-25 | 2017-07-05 | Novartis Ag | Ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors. |
| RS63405B1 (sr) | 2013-10-25 | 2022-08-31 | Blueprint Medicines Corp | Inhibitori receptora faktora rasta fibroblasta |
| US9695165B2 (en) * | 2014-01-15 | 2017-07-04 | Blueprint Medicines Corporation | Inhibitors of the fibroblast growth factor receptor |
| US10125090B2 (en) | 2014-06-24 | 2018-11-13 | Covestro Deutschland Ag | Process for preparation of di- and polyamines of the diphenylmethane series |
| US20160115164A1 (en) | 2014-10-22 | 2016-04-28 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
| EP3029864B1 (en) | 2014-12-01 | 2020-11-18 | Harman Becker Automotive Systems GmbH | Fast representation of station information in a fm receiver using a single tuner |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| TWI712601B (zh) | 2015-02-20 | 2020-12-11 | 美商英塞特公司 | 作為fgfr抑制劑之雙環雜環 |
| US9580423B2 (en) * | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| CN105906630B (zh) | 2015-04-06 | 2018-10-23 | 四川百利药业有限责任公司 | 用作fgfr抑制剂的n-(1h-吡唑-5-基)嘧啶并吡唑-4,6-二取代胺类化合物 |
| WO2016164703A1 (en) | 2015-04-09 | 2016-10-13 | Eisai R & D Management Co., Ltd. | Fgfr4 inhibitors |
| CN107286130A (zh) * | 2016-04-13 | 2017-10-24 | 成都融科博海科技有限公司 | 一种激酶选择性抑制剂 |
| AU2017378943B2 (en) * | 2016-12-19 | 2020-06-18 | Abbisko Therapeutics Co., Ltd. | FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereof |
| CA3074885A1 (en) * | 2017-09-05 | 2019-03-14 | Bioardis Llc | Aromatic derivative, preparation method for same, and medical applications thereof |
| CN109224235B (zh) | 2018-10-23 | 2020-05-19 | 孙喜家 | 一种双腔管 |
| CN109331654A (zh) | 2018-10-26 | 2019-02-15 | 高邮高和光电器材有限公司 | 一种有机废气光催化氧化装置 |
-
2019
- 2019-03-05 WO PCT/CN2019/076926 patent/WO2020177067A1/en not_active Ceased
-
2020
- 2020-02-19 JP JP2021552591A patent/JP7470708B2/ja active Active
- 2020-02-19 CA CA3132405A patent/CA3132405A1/en active Pending
- 2020-02-19 CN CN202080000743.2A patent/CN111902400B/zh active Active
- 2020-02-19 EP EP20767365.8A patent/EP3935048A4/en not_active Withdrawn
- 2020-02-19 PH PH1/2021/552133A patent/PH12021552133A1/en unknown
- 2020-02-19 SG SG11202109522VA patent/SG11202109522VA/en unknown
- 2020-02-19 WO PCT/CN2020/075849 patent/WO2020177534A1/en not_active Ceased
- 2020-02-19 KR KR1020217031713A patent/KR20210135558A/ko not_active Ceased
- 2020-02-19 US US17/436,476 patent/US11976058B2/en active Active
- 2020-03-05 TW TW109107205A patent/TWI860334B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534124A5 (https=) | ||
| JP2023515617A5 (https=) | ||
| JP6466348B2 (ja) | スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用 | |
| JP2022522890A5 (https=) | ||
| JP2007502264A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2023515620A5 (https=) | ||
| JP2021532124A5 (https=) | ||
| JP2023520925A5 (https=) | ||
| JP2012530703A5 (https=) | ||
| JP2023515621A5 (https=) | ||
| JP2023520924A5 (https=) | ||
| JP2023520916A5 (https=) | ||
| JP2023541522A5 (https=) | ||
| JP2015533782A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2025071130A5 (https=) | ||
| JP2008509187A5 (https=) | ||
| RU2003105885A (ru) | Ингибиторы клеточной адгезии, опосредованной альфа 4-интегринами | |
| JP2006509749A5 (https=) | ||
| JP2012236838A5 (https=) | ||
| JP2015524472A5 (https=) | ||
| JP2024513227A5 (https=) | ||
| JP2022501429A5 (https=) | ||
| BR112015029463B1 (pt) | Bissulfato de inibidor da janus quinase (jak), seu uso e seu método de preparação, e composição farmacêutica | |
| JP2013542267A5 (https=) |